pDONR223-HK2 Citations (3)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal

---

Articles Citing pDONR223-HK2

Articles
Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. McCoy MK, Kaganovich A, Rudenko IN, Ding J, Cookson MR. Hum Mol Genet. 2014 Jan 1;23(1):145-56. doi: 10.1093/hmg/ddt407. Epub 2013 Aug 19. PubMed
Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer. Anderson M, Marayati R, Moffitt R, Yeh JJ. Oncotarget. 2016 Jun 1;8(34):56081-56094. doi: 10.18632/oncotarget.9760. eCollection 2017 Aug 22. PubMed
Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression. Wu Z, Han X, Tan G, Zhu Q, Chen H, Xia Y, Gong J, Wang Z, Wang Y, Yan J. Onco Targets Ther. 2020 Jan 6;13:31-44. doi: 10.2147/OTT.S224062. eCollection 2020. PubMed

If you have published an article using this material, please email us at to have your article added to this page.